Form 8-K - Current report:
SEC Accession No. 0001493152-24-041287
Filing Date
2024-10-16
Accepted
2024-10-16 15:55:25
Documents
13
Period of Report
2024-10-07
Items
Item 3.02: Unregistered Sales of Equity Securities

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 36531
  Complete submission text file 0001493152-24-041287.txt   206583

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sigy-20241007.xsd EX-101.SCH 3042
3 XBRL LABEL FILE sigy-20241007_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE sigy-20241007_pre.xml EX-101.PRE 24183
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3371
Mailing Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212
Business Address 9190 W OLYMPIC BLVD # 263 BEVERLY HILLS CA 90212 619-368-2000
Sigyn Therapeutics, Inc. (Filer) CIK: 0001642159 (see all company filings)

EIN.: 472573116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55575 | Film No.: 241374545
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)